Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Su

Showing results (1041-1050 of 1,172) with videos related to

Pageof 118
Sort By:
European Journal of Medicinal Chemistry|October 28, 2020
Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumorsHao-Yue Xiang, Xiang Wang, Yan-Hong Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2019
Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 alleleValentina Ghisays, Dhruman D Goradia, Hillary Protas, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Antigen-specific T cell immunotherapy by in vivo mRNA deliveryFang-Yi Su, Jamison C Siebart, Ching S Chan, et al.
Circulation Research|January 22, 2019
Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured HeartGyu Seong Heo, Benjamin Kopecky, Deborah Sultan, et al.
European Journal of Medicinal Chemistry|August 11, 2023
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activitiesPingyuan Wang, Wen-Ting Zhu, Yajing Wang, et al.
Scientific Reports|August 11, 2016
Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesisChi-Kuan Chen, Wen-Hsuan Yu, Tsu-Yao Cheng, et al.
Neuroimage. Clinical|March 23, 2019
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's diseaseQing Wang, Yong Wang, Jingxia Liu, et al.
Oncotargets and Therapy|June 13, 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
American Journal of Respiratory and Critical Care Medicine|November 2, 2010
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitorTzu-Hua Chang, Meng-Feng Tsai, Kang-Yi Su, et al.
Clinical Kidney Journal|January 12, 2024
Ambient temperature and the occurrence of intradialytic hypotension in patients receiving hemodialysisKuan-Hung Liu, Wei-Hsiang Chang, Edward Chia-Cheng Lai, et al.
Pageof 118

Showing results (1041-1050 of 1,172) with videos related to

Sort By:
Pageof 118
European Journal of Medicinal Chemistry|October 28, 2020
Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumorsHao-Yue Xiang, Xiang Wang, Yan-Hong Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2019
Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 alleleValentina Ghisays, Dhruman D Goradia, Hillary Protas, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Antigen-specific T cell immunotherapy by in vivo mRNA deliveryFang-Yi Su, Jamison C Siebart, Ching S Chan, et al.
Circulation Research|January 22, 2019
Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured HeartGyu Seong Heo, Benjamin Kopecky, Deborah Sultan, et al.
European Journal of Medicinal Chemistry|August 11, 2023
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activitiesPingyuan Wang, Wen-Ting Zhu, Yajing Wang, et al.
Scientific Reports|August 11, 2016
Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesisChi-Kuan Chen, Wen-Hsuan Yu, Tsu-Yao Cheng, et al.
Neuroimage. Clinical|March 23, 2019
Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's diseaseQing Wang, Yong Wang, Jingxia Liu, et al.
Oncotargets and Therapy|June 13, 2014
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinomaJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
American Journal of Respiratory and Critical Care Medicine|November 2, 2010
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitorTzu-Hua Chang, Meng-Feng Tsai, Kang-Yi Su, et al.
Clinical Kidney Journal|January 12, 2024
Ambient temperature and the occurrence of intradialytic hypotension in patients receiving hemodialysisKuan-Hung Liu, Wei-Hsiang Chang, Edward Chia-Cheng Lai, et al.
Pageof 118